Mercado Eva, Paniagua Nancy, Sánchez-Robles Eva M, Girón Rocío, Alvarez de la Rosa Diego, Giraldez Teresa, Goicoechea Carlos
Department of Health Basic Sciences, Faculty of Health Sciences, Universidad Rey Juan Carlos, High Performance Research Group in Experimental Pharmacology (PHARMAKOM), Unidad Asociada I+D+i al Instituto de Química Médica (CSIC), Alcorcón, Madrid, Spain.
Department of Basic Medical Sciences and Institute of Biomedical Technologies (ITB), Universidad de La Laguna, Tenerife, Spain.
Pharmacol Biochem Behav. 2022 Jan;212:173302. doi: 10.1016/j.pbb.2021.173302. Epub 2021 Nov 24.
The serum and glucocorticoid-regulated kinase 1 (SGK1) is a widely expressed protein in the Central Nervous System (CNS), involved in regulating the activity of a wide variety of ion channels and transporters and physiological functions, such as neuronal excitability. SGK1.1 is a neuronal splice isoform of SGK1, expressed exclusively in the CNS, distributed in brain and cerebellum, that decreases neuronal excitability via up-regulation of M-current, linked to Kv7.2/3 potassium channels. Strategies to maintain increased SGK1.1 activity could be helpful in decreasing neuronal hyperexcitability, as occurs in neuropathic pain. Transgenic mice overexpressing SGK1.1 (B6.Tg.sgk1) offer a particularly relevant opportunity to assess the physiological involvement of this protein in nociception. Behavior and physiological nociception were evaluated in male and female B6.Tg.sgk1 and wild-type mice (B6.WT), characterizing nociceptive thresholds to different nociceptive stimuli (thermal, chemical and mechanical), as well as the electrophysiological properties of cutaneous sensory Aδ-fibres isolated from the saphenous nerve. The acute antinociceptive effect of morphine was also evaluated. Compared with B6.WT animals, male and female B6.Tg.sgk1 mice showed increased spontaneous locomotor activity. Regarding nociception, there were no differences between transgenic and wild-type mice in heat, chemical and mechanical thresholds, but interestingly, male B6.Tg.sgk1 mice were less sensitive to cold stimulus; B6.Tg.sgk1 animals showed lower sensitivity to morphine. Electrophysiological properties of cutaneous primary afferent fibres were maintained. This is the first demonstration that the SGK1.1 isoform is involved in nociceptive modulation, offering a protective effect against noxious cold stimulus in a sexually dimorphic manner. B6.Tg.sgk1 mice offer a particularly relevant opportunity to further analyze the involvement of this protein in nociception, and studies in models of chronic, neuropathic pain are warranted.
血清和糖皮质激素调节激酶1(SGK1)是一种在中枢神经系统(CNS)中广泛表达的蛋白质,参与调节多种离子通道和转运体的活性以及生理功能,如神经元兴奋性。SGK1.1是SGK1的一种神经元剪接异构体,仅在中枢神经系统中表达,分布于大脑和小脑,通过上调与Kv7.2/3钾通道相关的M电流来降低神经元兴奋性。维持SGK1.1活性增加的策略可能有助于降低神经元的过度兴奋性,如在神经性疼痛中发生的那样。过表达SGK1.1的转基因小鼠(B6.Tg.sgk1)为评估该蛋白在痛觉中的生理作用提供了一个特别相关的机会。对雄性和雌性B6.Tg.sgk1和野生型小鼠(B6.WT)的行为和生理痛觉进行了评估,确定了对不同痛觉刺激(热、化学和机械)的痛觉阈值,以及从隐神经分离的皮肤感觉Aδ纤维的电生理特性。还评估了吗啡的急性镇痛作用。与B6.WT动物相比,雄性和雌性B6.Tg.sgk1小鼠的自发运动活动增加。关于痛觉,转基因小鼠和野生型小鼠在热、化学和机械阈值方面没有差异,但有趣的是,雄性B6.Tg.sgk1小鼠对冷刺激的敏感性较低;B6.Tg.sgk1动物对吗啡的敏感性较低。皮肤初级传入纤维的电生理特性得以维持。这是首次证明SGK1.1异构体参与痛觉调制,以性别二态性方式对有害冷刺激提供保护作用。B6.Tg.sgk1小鼠为进一步分析该蛋白在痛觉中的作用提供了一个特别相关的机会,有必要在慢性神经性疼痛模型中进行研究。